Monte Rosa Therapeutics, Inc. Profile Avatar - Palmy Investing

Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral mol…

Biotechnology
US, Boston [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Monte Rosa Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Monte Rosa Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Monte Rosa Therapeutics, Inc..

End of GLUE's Analysis
CIK: 1826457 CUSIP: 61225M102 ISIN: US61225M1027 LEI: - UEI: -
Secondary Listings
GLUE has no secondary listings inside our databases.